A detailed history of First Manhattan CO transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, First Manhattan CO holds 886,330 shares of TMO stock, worth $481 Million. This represents 1.72% of its overall portfolio holdings.

Number of Shares
886,330
Previous 905,632 2.13%
Holding current value
$481 Million
Previous $501 Million 9.47%
% of portfolio
1.72%
Previous 1.69%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$531.86 - $624.21 $10.3 Million - $12 Million
-19,302 Reduced 2.13%
886,330 $548 Million
Q2 2024

Aug 13, 2024

SELL
$541.52 - $599.02 $4.27 Million - $4.72 Million
-7,885 Reduced 0.86%
905,632 $501 Million
Q1 2024

May 15, 2024

SELL
$528.82 - $599.43 $2.27 Million - $2.57 Million
-4,294 Reduced 0.47%
913,517 $531 Million
Q4 2023

Feb 13, 2024

SELL
$431.41 - $532.94 $44.3 Million - $54.7 Million
-102,628 Reduced 10.06%
917,811 $487 Million
Q3 2023

Nov 14, 2023

BUY
$498.29 - $574.41 $29.3 Million - $33.7 Million
58,734 Added 6.11%
1,020,439 $517 Million
Q2 2023

Aug 14, 2023

BUY
$508.46 - $591.13 $120 Million - $140 Million
236,861 Added 32.68%
961,705 $502 Million
Q1 2023

May 15, 2023

BUY
$535.0 - $604.82 $38.9 Million - $44 Million
72,792 Added 11.16%
724,844 $418 Million
Q4 2022

Feb 14, 2023

BUY
$484.71 - $571.37 $6.33 Million - $7.46 Million
13,055 Added 2.04%
652,052 $359 Million
Q3 2022

Nov 14, 2022

SELL
$507.19 - $604.49 $2.27 Million - $2.7 Million
-4,474 Reduced 0.7%
638,997 $323 Million
Q2 2022

Aug 15, 2022

BUY
$500.9 - $612.21 $6.43 Million - $7.86 Million
12,837 Added 2.04%
643,471 $348 Million
Q1 2022

May 16, 2022

SELL
$524.0 - $644.92 $2.35 Million - $2.9 Million
-4,491 Reduced 0.71%
630,634 $372 Million
Q4 2021

Feb 14, 2022

SELL
$569.0 - $667.24 $1.58 Million - $1.85 Million
-2,780 Reduced 0.44%
635,125 $424 Million
Q3 2021

Nov 15, 2021

BUY
$509.53 - $609.78 $1.42 Million - $1.7 Million
2,789 Added 0.44%
637,905 $364 Million
Q2 2021

Aug 16, 2021

BUY
$441.0 - $508.24 $39.8 Million - $45.9 Million
90,345 Added 16.58%
635,116 $320 Million
Q1 2021

May 14, 2021

BUY
$439.85 - $518.83 $845,391 - $997,191
1,922 Added 0.35%
544,771 $249 Million
Q4 2020

Feb 16, 2021

SELL
$435.06 - $527.66 $4.31 Million - $5.22 Million
-9,896 Reduced 1.79%
542,849 $253 Million
Q3 2020

Nov 12, 2020

BUY
$359.77 - $441.52 $4.98 Million - $6.11 Million
13,834 Added 2.57%
552,745 $244 Million
Q2 2020

Aug 14, 2020

SELL
$275.2 - $362.34 $4.77 Million - $6.28 Million
-17,342 Reduced 3.12%
538,911 $195 Million
Q1 2020

May 06, 2020

SELL
$255.3 - $340.05 $1.2 Million - $1.6 Million
-4,702 Reduced 0.84%
556,253 $158 Million
Q4 2019

Feb 13, 2020

SELL
$271.93 - $328.04 $1.92 Million - $2.32 Million
-7,069 Reduced 1.24%
560,955 $182 Million
Q3 2019

Nov 13, 2019

SELL
$268.46 - $305.43 $48,591 - $55,282
-181 Reduced 0.03%
568,024 $165 Million
Q2 2019

Aug 16, 2019

BUY
$257.51 - $295.55 $15.7 Million - $18 Million
60,829 Added 11.99%
568,205 $167 Million
Q1 2019

Apr 12, 2019

BUY
$212.17 - $273.72 $3.86 Million - $4.98 Million
18,184 Added 3.72%
507,376 $139 Million
Q4 2018

Jan 30, 2019

SELL
$208.47 - $251.98 $2.58 Million - $3.12 Million
-12,370 Reduced 2.47%
489,192 $109 Million
Q3 2018

Oct 15, 2018

SELL
$205.57 - $244.32 $1.49 Million - $1.77 Million
-7,253 Reduced 1.43%
501,562 $122 Million
Q2 2018

Aug 01, 2018

SELL
$203.14 - $219.53 $1.52 Million - $1.64 Million
-7,483 Reduced 1.45%
508,815 $105 Million
Q1 2018

Apr 20, 2018

SELL
$192.98 - $224.11 $2.59 Million - $3 Million
-13,398 Reduced 2.53%
516,298 $107 Million
Q4 2017

Jan 22, 2018

SELL
$182.03 - $200.37 $440,330 - $484,695
-2,419 Reduced 0.45%
529,696 $101 Million
Q3 2017

Oct 25, 2017

BUY
$171.74 - $194.04 $91.4 Million - $103 Million
532,115
532,115 $101 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $212B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track First Manhattan CO Portfolio

Follow First Manhattan CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.